“Dost” Model to Link and Support Drug Resistant TB Patients From Private Sector
An Experience From Delhi, India
Bibliographic Data
| ID | 22091619 |
|---|---|
| Authors | Vindhya Vatsyayan (0009-0009-2655-8743), Theresa Pattery (0000-0002-8973-2165), Khasim Sayyad, Jason Williams (0000-0002-5355-3210), Arnab Pal (0000-0003-2161-7520), Vikas Panibatla (0000-0002-6702-0669, corresponding author), Ashwani Khanna (0000-0001-9295-997X, New Delhi Tuberculosis Center) |
| Year | 2022 |
| Volume | 10 |
| Pages | 835055-835055 |
| Publication date | 2022-05-11 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2022.835055 |
| PMID | 35646807 |
| OpenAlex | W4280498638 |
| Language | EN |
| Citations received | 1 |
| References cited | 2 |
Background: The National TB Elimination Programme (NTEP) has quite successfully involved private sector for referral of presumptive drug resistant TB (DR-TB) patients for molecular testing and referral for DR-TB management. There was a challenge as all the referred patients were not reaching to the facilities. A "DOST" intervention model was implemented to strengthen the patient care pathway. We conducted this study to describe the patient care cascade, the clinico-demographic characteristics of patients linked to the treatment and to estimate the mean turn-around time for drug resistant TB care services. Methods: It is a cross-sectional study conducted at New Delhi during the period July 2019-December 2020 under programmatic settings. Results: A total of 9,331 patients were subjected to CB-NAAT test and 382 (4%) were found to be resistant for rifampicin and 231 (76%) were initiated on treatment in the public sector under NTEP. Conclusion: The DOST intervention model developed to link the DR-TB patients from private sector to the public sector DR-TB centers is found to be efficient and effective
Economic growth · Family medicine · Pathology · Private sector · Public sector · Referral · Rifampicin · Tuberculosis · Diverse Scientific Research Studies · Healthcare Facilities Design and Sustainability · Medicine · Nursing · Tuberculosis Research and Epidemiology
| Citations per year | 1 |
|---|---|
| Citation span | 2025 - 2025 (1) |
| Highly cited | No |